Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
- 20 July 1982
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 73 (1), 229-235
- https://doi.org/10.1016/0002-9343(82)90097-3
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with AcyclovirNew England Journal of Medicine, 1982
- Fatal vidarabine toxicity in a patient with normal renal functionJAMA, 1981
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- The Course of Untreated Recurrent Genital Herpes Simplex Infection in 27 WomenNew England Journal of Medicine, 1981
- Ineffectiveness of Topical Adenine Arabinoside 5′-Monophosphate in the Treatment of Recurrent Herpes Simplex LabialisNew England Journal of Medicine, 1979
- Ineffectiveness of Topical Ether for the Treatment of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1978
- Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex EncephalitisNew England Journal of Medicine, 1977
- The Natural History of Recurrent Herpes Simplex LabialisNew England Journal of Medicine, 1977
- Cellular Immune Responses to Herpesviruses during Treatment with Adenine ArabinosideThe Journal of Infectious Diseases, 1977
- Effect of Adenine Arabinoside on Severe Herpesvirus hominis Infections in ManThe Journal of Infectious Diseases, 1973